GlassScriptPhysician profile
Marc Y Wasserman
NPI 1356340467
$10,232.93
in general payments reported to CMS, 2019-2025
62 companies · $1,222 in 2025
The $1,222 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,460 · 2020: $797 · 2021: $2,009 · 2022: $944 · 2023: $792 · 2024: $1,008 · 2025: $1,222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,022.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,022.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,753.87 | 2019-2025 | Ubrelvy, Botox, Qulipta |
| Neurocrine Biosciences, INC. | $611.88 | 2019-2024 | Ingrezza |
| Lilly USA, LLC | $510.68 | 2019-2025 | Kisunla, Amyvid, Reyvow |
| Ucb, INC. | $509.39 | 2019-2024 | Nayzilam, Fintepla |
| Amgen INC. | $485.19 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $434.05 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $410.67 | 2022 | |
| Sk Life Science, INC. | $404.41 | 2021-2025 | |
| Eisai INC. | $386.03 | 2019-2021 | |
| Lundbeck LLC | $361.97 | 2019-2025 | Vyepti |
| Genzyme Corporation | $343.00 | 2019-2022 | |
| Medtronic USA, INC. | $271.13 | 2019-2020 | |
| Allergan, INC. | $258.08 | 2019-2021 | |
| Pfizer INC. | $254.93 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $217.38 | 2019-2025 | Austedo Xr |
Show all 62 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Wasserman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.